<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00861263</url>
  </required_header>
  <id_info>
    <org_study_id>Spirus Overtube</org_study_id>
    <nct_id>NCT00861263</nct_id>
  </id_info>
  <brief_title>The Clinical Utility of Overtube Use at the Time of Endoscopy</brief_title>
  <acronym>Spirus</acronym>
  <official_title>The Clinical Utility of Overtube Use at the Time of Endoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopy has become a vital part of the gastroenterologist's evaluation and treatment of
      disorders involving the gastrointestinal (GI) tract. The small bowel is an area of the GI
      tract, which can prove difficult to visualize during an endoscopy specifically designed to
      evaluate it, termed enteroscopy. Thus, the FDA has approved overtubes, such as the Endo-Ease®
      spiral overtube (Spirus Medical, Inc.) or EnteroPro® balloon overtube (Olympus Medical,
      Inc.), to facilitate passage of the endoscope through the GI tract. The aims of the study are
      to evaluate the efficiency of an overtube system for visualization of small bowel. The
      hypothesis is that this will permit more complete and efficient evaluation of the small
      intestine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Persistent or Recurrent Bleeding</measure>
    <time_frame>up to 6 yrs after after the endoscopy</time_frame>
    <description>The number of patients that had persistent or recurrent GI bleeding after spiral enteroscopy.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">193</enrollment>
  <condition>Small Bowel Visualization</condition>
  <arm_group>
    <arm_group_label>spiral overtube</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Any subject that has been referred for spiral enteroscopy will be asked to participate in this study. The purpose is to gather data about the technical aspects of the procedure,diagnostic capability and treatment as well as long term follow up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>overtube use during enteroscopy</intervention_name>
    <description>use of overtube for the regular scheduled enteroscopy</description>
    <arm_group_label>spiral overtube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects ≥ 18 years.

          2. Have an indication for enteroscopy as determined by the patient's physicians. These
             indications include, but are not limited to, obscure gastrointestinal bleeding,
             malabsorption, suspected small bowel tumor, small bowel strictures, small bowel
             ulceration, and abnormal imaging of the small bowel.

          3. Scheduled to undergo enteroscopy at the University of Florida, Gainesville, Florida,
             as medically indicated.

          4. Subject must be able to give informed consent.

        Exclusion Criteria:

          1. Platelets &lt; 75,000.

          2. INR &gt; 1.6.

          3. NSAIDS within 48 hours of procedure.

          4. Pregnancy.

          5. Esophageal stricture.

          6. Inability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Draganov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida, Division of Gastroenterology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shands at UF</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2009</study_first_submitted>
  <study_first_submitted_qc>March 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2009</study_first_posted>
  <results_first_submitted>November 12, 2013</results_first_submitted>
  <results_first_submitted_qc>March 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 14, 2014</results_first_posted>
  <last_update_submitted>March 7, 2014</last_update_submitted>
  <last_update_submitted_qc>March 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We started this study in June 2007 and ended this study in Oct 2012. We approached any patient who was scheduled in our endoscopy suite for an overtube enteroscopy.</recruitment_details>
      <pre_assignment_details>The only significant event was that the subject was scheduled for an enteroscopy in our facility and a overtube was used at the time of endoscopy.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Enteroscopy</title>
          <description>Any subject who was referred for an enteroscopy to our facility and an overtube was used at the time of endoscopy was asked to participate in this study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="193"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="193"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Enteroscopy</title>
          <description>Any subject who was referred for an enteroscopy to our facility and an overtube was used at the time of endoscopy was asked to participate in this study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="193"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Persistent or Recurrent Bleeding</title>
        <description>The number of patients that had persistent or recurrent GI bleeding after spiral enteroscopy.</description>
        <time_frame>up to 6 yrs after after the endoscopy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Spiral Enteroscopy Subjects</title>
            <description>All subjects followed up after spiral enteroscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Persistent or Recurrent Bleeding</title>
          <description>The number of patients that had persistent or recurrent GI bleeding after spiral enteroscopy.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse event data were collected for 6 years.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Enteroscopy</title>
          <description>Any subject who was referred for an enteroscopy to our facility and an overtube was used at the time of endoscopy was asked to participate in this study.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="193"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <description>Two subjects experienced bradycardias during endoscopy and were hospitalized overnight for observation.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="193"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <description>One subject experience Chest pain after endoscopy and was hospitalized overnight for observation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="193"/>
              </event>
              <event>
                <sub_title>Ventrical Tachycardia Arrest</sub_title>
                <description>One subject experienced a ventrical tachycardia arrest and was hospitalized.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="193"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Partial Thickness Mucosal Tear</sub_title>
                <description>Three subjects experienced a partial thickness mucosal tear as part of their endoscopy.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="193"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Transient Ischemic Attack</sub_title>
                <description>One subject experienced a transient ischemic attack after endoscopy and was hospitalized overnight for observation.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="193"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="193"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No limitations were found</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Peter Draganov MD</name_or_title>
      <organization>University of FLorida</organization>
      <phone>352-273-9472</phone>
      <email>peter.draganov@medicine.ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

